Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
innovation crawled date : 2022 - 06 - 06 save search
AnHeart Therapeutics and Innovent Biologics Present Updated Phase 2 Efficacy and Safety Data of Taletrectinib (ROS1 Inhibitor) at ASCO 2022
Published: 2022-06-06 (Crawled : 16:00) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 3.83%
H: 0.0%
C: 0.0%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
therapeutics asco phase 2
Cisco Unveils Innovations Driving New Security Cloud Strategy
Published: 2022-06-06 (Crawled : 15:20) - prnewswire.com
CSCO | News | $48.33 0.02% 0.02% 14M
|
Technology Services
|
| O: 0.78%
H: 1.07%
C: -0.6%
security cloud
Professional Development Market Size in the US to Grow by USD 3.75 billion | Innovations in Technology to Drive Growth | Technavio
Published: 2022-06-06 (Crawled : 12:20) - prnewswire.com
ADBE A | $477.11 0.89% 0.88% 2M
|
Technology Services
|
| O: 1.28%
H: 0.55%
C: -1.86%
technology growth market
Tiziana Life Sciences to Present at the 2022 Biotechnology Innovation Organization Annual Convention to Discuss Recent Updates to Ongoing Clinical Programs
Published: 2022-06-06 (Crawled : 12:00) - biospace.com/
TLSA | News | $0.781 0.77% 0.77% 330K
|
Health Technology
|
| O: -2.78%
H: 3.9%
C: -3.16%
ongoing sciences life innovation
Bruker Announces Key Innovations for Highly Multiplexed Spatial Proteomics and Multiomic Tissue Imaging at Large Field-of-View
Published: 2022-06-06 (Crawled : 12:00) - biospace.com/
BRKR | $82.21 -0.3% -0.3% 980K
|
Health Technology
|
| O: 0.09%
H: 0.44%
C: -0.77%
imaging
Innovent and IASO Bio Jointly Announce the NMPA Acceptance of the New Drug Application for Equecabtagene Autoleucel for the Treatment of Relapsed and/or Refractory Multiple Myeloma
Published: 2022-06-06 (Crawled : 01:00) - prnewswire.com
SANA | $8.58 6.06% 5.71% 1.2M
|
|
| O: 5.56%
H: 2.46%
C: -13.16%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 3.83%
H: 0.0%
C: 0.0%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
treatment drug application
Innovent Presents Clinical Data of Phase I Study for IBI351 (KRAS G12C Inhibitor) as Monotherapy for Solid Tumors at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2022-06-06 (Crawled : 01:00) - prnewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 3.83%
H: 0.0%
C: 0.0%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
ibi351
Innovent Presents Clinical Data of IBI110 (Anti-LAG-3 Monoclonal Antibody) at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2022-06-06 (Crawled : 01:00) - prnewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 3.83%
H: 0.0%
C: 0.0%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
ibi110 antibody
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.